Common Use

Cyclomune (cyclosporine) is an immunosuppressive medication widely used in veterinary medicine for the management of canine atopic dermatitis, a chronic allergic skin condition that causes intense itching, redness, and skin inflammation in dogs. As a calcineurin inhibitor, cyclosporine works by suppressing the overactive immune response responsible for allergic skin reactions, effectively reducing the itching, scratching, and skin damage associated with atopic dermatitis. Beyond dermatological conditions, Cyclomune may also be prescribed by veterinarians for other immune-mediated or autoimmune disorders in dogs, including perianal fistulas, inflammatory bowel disease, immune-mediated hemolytic anemia, and other conditions where immune system modulation is therapeutically beneficial. Patients who buy Cyclomune online for their dogs appreciate its proven track record in providing sustained relief from chronic allergic skin disease. Long-term therapy is often required to maintain clinical improvement and prevent symptom recurrence.

Dosage and Direction

The dosage of Cyclomune is carefully determined based on the dog's body weight, specific diagnosis, and individual clinical response. The typical starting dose of cyclosporine for canine atopic dermatitis is 5 mg per kilogram of body weight, administered orally once daily. Capsules should be given whole and swallowed intact — do not open, crush, or chew them. For optimal and consistent absorption, administer Cyclomune at the same time each day, ideally at least two hours before or after feeding. Treatment duration varies depending on the condition being treated and the dog's response; some dogs may require long-term or lifelong therapy. After the initial treatment period (typically four to eight weeks), the veterinarian may attempt to reduce the dose or frequency to the lowest effective level for maintenance. Regular veterinary follow-up is essential throughout treatment.

Precautions

Cyclomune should be used with caution in animals with a history of recurrent bacterial, viral, or fungal infections, as cyclosporine is an immunosuppressive agent that reduces the body's ability to fight infections. Dogs with pre-existing liver disorders should be closely monitored, as cyclosporine is extensively metabolized in the liver. Regular veterinary monitoring — including blood work to assess cyclosporine levels, liver function, kidney function, and complete blood counts — is recommended throughout therapy. Animals receiving Cyclomune may be more susceptible to opportunistic infections and should be monitored for signs of illness such as fever, lethargy, or unusual discharge. Any unusual symptoms or behavioral changes should be reported to the veterinarian promptly. Vaccination efficacy may be reduced during cyclosporine therapy.

Contraindications

Cyclomune is contraindicated in animals with known hypersensitivity to cyclosporine or any component of the formulation. It should not be used in dogs with active, uncontrolled infections (bacterial, fungal, or viral), as immunosuppression may worsen the infection. Cyclomune is contraindicated in animals with diagnosed malignant disorders or a history of neoplasia, since immunosuppressive therapy may promote tumor growth. Use in very young puppies, pregnant dogs, or breeding animals should be avoided unless specifically recommended by the attending veterinarian after careful assessment of the benefit-risk ratio. Dogs should be tested for heartworm infection and other parasitic diseases before initiating cyclosporine therapy.

Possible Side Effects

The most commonly reported side effects of Cyclomune in dogs include gastrointestinal disturbances such as vomiting, diarrhea, decreased appetite, and soft stools, particularly during the initial weeks of treatment. These effects are generally mild to moderate, often dose-dependent, and frequently resolve on their own as the dog adjusts to the medication. Gingival hyperplasia (overgrowth of gum tissue) and hypertrichosis (excessive hair growth) may occur with long-term use. Due to the immunosuppressive nature of cyclosporine, there is an inherently increased risk of bacterial, viral, and fungal infections during therapy. Less commonly, papillomatosis (wart-like growths) may develop. Most adverse effects are reversible upon dose reduction or discontinuation of treatment.

Drug Interaction

Cyclomune may interact with several other medications, and it is important to inform the veterinarian about all drugs and supplements being administered. Azole antifungals (such as ketoconazole and itraconazole) can significantly increase cyclosporine blood levels, potentially requiring dose adjustment. Other immunosuppressive medications used concurrently may result in excessive immunosuppression. Certain antibiotics (such as erythromycin) and calcium channel blockers may also elevate cyclosporine concentrations. Drugs that induce liver enzymes (such as phenobarbital or rifampin) may decrease cyclosporine levels and reduce its effectiveness. Careful dose adjustment and therapeutic drug monitoring may be required when Cyclomune is used alongside other medications.

Missed Dose

If a dose of Cyclomune is missed, it should be administered as soon as remembered. If it is nearly time for the next scheduled dose, the missed dose should be skipped — do not administer a double dose to compensate. Resume the regular dosing schedule as directed by the veterinarian. Consistent daily dosing is important for maintaining therapeutic cyclosporine blood levels and optimal symptom control.

Overdose

Overdose of Cyclomune may lead to severe gastrointestinal disturbances (profuse vomiting and diarrhea), excessive immunosuppression, and potentially life-threatening secondary infections. Prolonged overdose or chronic excessive dosing can further increase the risk of serious opportunistic infections and other complications. If an overdose is suspected, veterinary attention should be sought immediately. Treatment is generally symptomatic and supportive, and may include gastrointestinal decontamination if the overdose was recent.

Storage

Cyclomune should be stored at controlled room temperature between 15 and 25 degrees Celsius, in a dry place protected from light and moisture. Keep the medication in its original packaging until ready for use to protect from environmental degradation. Do not use after the expiration date printed on the packaging. Store out of reach of children and other animals.

Disclaimer

We provide only general information about medications which does not cover all directions, possible drug integrations, or precautions. Information at the site cannot be used for self-treatment and self-diagnosis. Any specific instructions for a particular patient should be agreed with your health care adviser or doctor in charge of the case. We disclaim reliability of this information and mistakes it could contain. We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on this site and also for consequences of self-treatment.